Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04576897 · ClinicalTrials.gov registry record · NA
Velacur by Sonic Incytes for Portal Hypertension
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT04576897 is a NA study that has completed, run by Indiana University. The registered enrollment target is 70 participants.
The verdict
NCT04576897, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
This is a cross sectional study that evaluates the relationship between LSM (liver stiffness measurement) by Liver Incytes in patients with cACLD (compensated advanced chronic liver disease) and manifestations of portal hypertension.
Interventions
- DIAGNOSTIC_TEST Velacur
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2021-02-01 |
| Est. Completion | 2022-04-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04576897
The ClinicalTrials.gov registry entry for NCT04576897 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Velacur is the first listed.
NCT04576897 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04576897 about?
NCT04576897 is a clinical study titled "Velacur by Sonic Incytes for Portal Hypertension". This is a cross sectional study that evaluates the relationship between LSM (liver stiffness measurement) by Liver Incytes in patients with cACLD (compensated advanced chronic liver disease) and manifestations of portal hypertension.
What is the current status of trial NCT04576897?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2021-02-01. Estimated completion is 2022-04-19.
What interventions are being tested in trial NCT04576897?
The interventions under investigation include: Velacur (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04576897?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.